Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19

Area of Science:

• Pulmonary Medicine
• Virology
• Immunology

Background:

• COVID-19 presents varied clinical stages impacting therapeutic strategies.
• Understanding disease progression in the pulmonary epithelium is crucial.
• Distinct cellular compositions and immune responses exist in conducting airways versus gas exchange regions.

Purpose of the Study:

• To provide background on COVID-19 progression within the pulmonary epithelium.
• To discuss therapeutic options based on infection location.
• To contrast infection dynamics in conducting airways and gas exchange lung portions.

Main Methods:

• Review of scientific literature on SARS-CoV-2 infection.
• Comparative analysis of cellular targets and immune responses.
• Discussion of therapeutic implications for different lung regions.

Main Results:

• SARS-CoV-2 targets ciliated cells in nasal airways, impairing mucociliary clearance with suppressed innate immunity.
• Alveolar type II cells are primary targets in gas exchange regions, leading to damage and potential acute respiratory distress syndrome.
• Asymptomatic individuals can transmit the virus despite productive infection.

Conclusions:

• Distinct therapeutic approaches are suggested for upper airway versus alveolar SARS-CoV-2 infections.
• Alveolar damage and hyperinflammation are key targets for severe COVID-19 therapies.
• Alveolar type II cell progenitor function may influence long-term lung sequelae.